指南与共识免疫规划

提供者推荐对13-17岁青少年Tdap疫苗接种的影响

Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years.
指南 / 共识 · Am J Prev Med · 2017-05-08

基于2013年美国全国青少年免疫调查数据(N=18,948),分析13-17岁青少年中提供者推荐与Tdap疫苗接种覆盖率的关系。仅56.9%青少年获得提供者推荐,有推荐者接种率88.6%显著高于无推荐者80.5%(p<0.05)。多因素回归显示提供者推荐等因素与更高接种可能性独立相关。

要点

  • 仅56.9%的13-17岁青少年获得提供者Tdap推荐。
  • 有提供者推荐者接种率88.6%,无推荐者80.5%,差异显著(p<0.05)。
  • 提供者推荐、西班牙裔、过去12个月2-3次医生接触等与更高接种可能性独立相关。

核心结论

  • 提供者推荐与13-17岁青少年Tdap疫苗接种显著相关。
  • 然而43%的青少年父母未收到提供者推荐。
  • 应采取基于证据的策略如单独使用标准医嘱和提供者提醒或联合卫生系统干预,以提高提供者推荐和Tdap疫苗接种覆盖率。

研究设计与样本

  • 分析2013年美国全国青少年免疫调查-青少年数据(N=18,948),于2016年进行。
  • 采用多变量logistic回归分析和预测边际模型评估Tdap疫苗接种与提供者推荐状态等因素的关联。

主要发现

  • 总体仅56.9%的13-17岁青少年获得提供者Tdap推荐。
  • 有提供者推荐者接种覆盖率88.6%,无推荐者80.5%,差异显著(p<0.05)。
  • 多变量logistic回归显示与更高Tdap接种可能性独立相关的特征包括:获得提供者推荐、西班牙裔、过去12个月有2-3次医生接触、有1-2个疫苗接种提供者、从超过一种类型的机构接种疫苗(p<0.05)。

临床怎么用

  • 原文建议采取基于证据的策略如单独使用标准医嘱和提供者提醒或联合卫生系统干预,以提高提供者推荐和Tdap疫苗接种覆盖率。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination has been recommended for adolescents in the U.S. since 2006. Information on Tdap vaccination by provider recommendation is limited. The purpose of this study is to assess recent Tdap vaccination by provider recommendation status among adolescents aged 13-17 years. METHODS: The 2013 National Immunization Survey-Teen data (N=18,948) were analyzed in 2016 to assess national and state-specific Tdap vaccination coverage disparities among adolescents by provider recommendation status, and other demographic and access to care variables. Multivariable logistic regression analysis and predictive marginal modeling evaluated associations between Tdap vaccination and provider recommendation status and other factors among adolescents aged 13-17 years. RESULTS: Overall, only 56.9% of adolescents aged 13-17 years received a provider recommendation for Tdap. Coverage was significantly higher among adolescents with a provider recommendation (88.6%) compared with those without a provider recommendation (80.5%) (p<0.05). Multivariable logistic regression showed that characteristics independently associated with a higher likelihood of Tdap vaccination included receiving a provider recommendation, Hispanic ethnicity, having two to three physician contacts in the past 12 months, having one or two vaccination providers, and receiving vaccinations from more than one type of facility (p<0.05). CONCLUSIONS: Provider recommendations were significantly associated with Tdap vaccination among adolescents aged 13-17 years. However, 43% of parents of adolescents did not receive a provider recommendation. Evidence-based strategies such as standing orders and provider reminders alone or health systems interventions in combination should be taken to improve provider recommendation and Tdap vaccination coverage.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Lu PJ, Yankey D, Jeyarajah J, et al. Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years. Am J Prev Med. 2017. PMID: 28495221. doi:10.1016/j.amepre.2017.03.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。